Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies

Jill A Ohar1 Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA, [email protected]Correspondence[email protected]

Alyssa Bowling2 Sunovion Pharmaceuticals Inc, Marlborough, MA, USA

Thomas Goodin2 Sunovion Pharmaceuticals Inc, Marlborough, MA, USA

Barry Price2 Sunovion Pharmaceuticals Inc, Marlborough, MA, USA

Ayca Ozol-Godfrey2 Sunovion Pharmaceuticals Inc, Marlborough, MA, USA

Sanjay Sharma2 Sunovion Pharmaceuticals Inc, Marlborough, MA, USA

Shahin Sanjar2 Sunovion Pharmaceuticals Inc, Marlborough, MA, USA

show all

Pages 461-470 | Published online: 19 Feb 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Claus F. Vogelmeier, Paul W. Jones, Edward M. Kerwin, Isabelle H. Boucot, François Maltais, Lee Tombs, Chris Compton, David A. Lipson & Leif H. Bjermer. (2021) Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial. Respiratory Research 22:1.
Crossref

Donald P. Tashkin, Xiaoli Niu, Sanjay Sharma & Shahin Sanjar. (2021) Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD. npj Primary Care Respiratory Medicine 31:1.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references